213 related articles for article (PubMed ID: 32192230)
1. Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry.
Zueva IV; Lushchekina SV; Daudé D; Chabrière E; Masson P
Molecules; 2020 Mar; 25(6):. PubMed ID: 32192230
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
3. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
[TBL] [Abstract][Full Text] [Related]
4. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
5. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
6. Interrogation of the Substrate Profile and Catalytic Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants and Plasticizers.
Xiang DF; Bigley AN; Ren Z; Xue H; Hull KG; Romo D; Raushel FM
Biochemistry; 2015 Dec; 54(51):7539-49. PubMed ID: 26629649
[TBL] [Abstract][Full Text] [Related]
7. Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.
Grigorenko BL; Novichkova DA; Lushchekina SV; Zueva IV; Schopfer LM; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Chem Biol Interact; 2019 Jun; 306():138-146. PubMed ID: 31009643
[TBL] [Abstract][Full Text] [Related]
8. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
9. The structure of G117H mutant of butyrylcholinesterase: nerve agents scavenger.
Amitay M; Shurki A
Proteins; 2009 Nov; 77(2):370-7. PubMed ID: 19452557
[TBL] [Abstract][Full Text] [Related]
10. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
[TBL] [Abstract][Full Text] [Related]
11. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
12. Mutant of Bungarus fasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters.
Poyot T; Nachon F; Froment MT; Loiodice M; Wieseler S; Schopfer LM; Lockridge O; Masson P
Biochim Biophys Acta; 2006 Sep; 1764(9):1470-8. PubMed ID: 16962835
[TBL] [Abstract][Full Text] [Related]
13. Engineering of a phosphotriesterase with improved stability and enhanced activity for detoxification of the pesticide metabolite malaoxon.
Job L; Köhler A; Testanera M; Escher B; Worek F; Skerra A
Protein Eng Des Sel; 2023 Jan; 36():. PubMed ID: 37941439
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.
Lushchekina SV; Schopfer LM; Grigorenko BL; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Front Pharmacol; 2018; 9():211. PubMed ID: 29593539
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications.
Ashani Y; Leader H; Aggarwal N; Silman I; Worek F; Sussman JL; Goldsmith M
Chem Biol Interact; 2016 Nov; 259(Pt B):252-256. PubMed ID: 27163850
[TBL] [Abstract][Full Text] [Related]
16. Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.
Köhler A; Escher B; Job L; Koller M; Thiermann H; Skerra A; Worek F
Arch Toxicol; 2021 Aug; 95(8):2815-2823. PubMed ID: 34160649
[TBL] [Abstract][Full Text] [Related]
17. X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.
Nachon F; Carletti E; Wandhammer M; Nicolet Y; Schopfer LM; Masson P; Lockridge O
Biochem J; 2011 Feb; 434(1):73-82. PubMed ID: 21091433
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of an organophosphate-detoxifying bacterial phosphotriesterase by albumin and plasma thiol components.
Köhler A; Job L; Worek F; Skerra A
Toxicol Lett; 2021 Oct; 350():194-201. PubMed ID: 34303790
[TBL] [Abstract][Full Text] [Related]
19. Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.
Yao Y; Liu J; Zhan CG
Biochemistry; 2012 Nov; 51(44):8980-92. PubMed ID: 23092211
[TBL] [Abstract][Full Text] [Related]
20. Engineering Dynamic Surface Peptide Networks on Butyrylcholinesterase
Hester KP; Bhattarai K; Jiang H; Agarwal PK; Pope C
Chem Res Toxicol; 2019 Sep; 32(9):1801-1810. PubMed ID: 31411024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
